Comparison of Venlafaxine Alone Versus Venlafaxine Plus Bright Light Therapy Combination for Severe Major Depressive Disorder
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Objective Phototherapy, ie, bright light therapy, is an effective and safe treatment of major depressive disorder (MDD). It exerts rapid mood-elevating activity, similar to antidepressant medications, most likely mediated through both monoaminergic and circadian system melatonergic mechanisms. We assessed the efficiency of bright light therapy as an adjuvant treatment to antidepressant pharmacotherapy in patients with severe MDD randomized by Hamilton Depression Rating Scale (HDRS) score to either (1) 150 mg venlafaxine hydrochloride daily at 7:00 AM or (2) 150 mg venlafaxine plus 60-minute light of 7000 lux the initial week of clinical management (venlafaxine + bright light therapy) daily at 7:00 AM. Method 50 inpatients with severe MDD at the Psychiatry Clinic of Yüzüncü Yıl University Training and Education Hospital participated. The study, which was conducted from January 2013 through June 2014, entailed patients diagnosed with severe MDD based on DSM-IV-TR for the first time. Mood states were assessed by the HDRS, Profile of Mood States (POMS), and Beck Depression Inventory (BDI) before treatment and at 1, 2, 4, and 8 weeks of treatment. Results On the basis of the HDRS score as the primary outcome variable, both strategies significantly improved depression and negative mood states already at the first treatment week (P Conclusions Both venlafaxine and venlafaxine + bright light therapy treatment strategies significantly reversed the depressive mood of patients with seve…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The combination of phototherapy and antidepressants has better effects than antidepressants alone. 402 , 405”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [405]
Citations
Cites
Light therapy for non-seasonal depression: systematic review and meta-analysis
Perera, S., Eisen, R., Bhatt, M., Bhatnagar, N., de Souza, R., Thabane, L., & Samaan, Z. (2016) · BJPsych Open · doi:10.1192/bjpo.bp.115.001610 · Cited by 153
The role of sleep in bipolar disorder
Gold, A., & Sylvia, L. (2016) · Nature and Science of Sleep · doi:10.2147/nss.s85754 · Cited by 146
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
Light therapy for non-seasonal depression: systematic review and meta-analysis
Perera, S., Eisen, R., Bhatt, M., Bhatnagar, N., de Souza, R., Thabane, L., & Samaan, Z. (2016) · BJPsych Open · doi:10.1192/bjpo.bp.115.001610 · Cited by 153
The role of sleep in bipolar disorder
Gold, A., & Sylvia, L. (2016) · Nature and Science of Sleep · doi:10.2147/nss.s85754 · Cited by 146
Light therapy in non-seasonal depression: An update meta-analysis
Tao, L., Jiang, R., Zhang, K., Qian, Z., Chen, P., Lv, Y., & Yao, Y. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113247 · Cited by 129
Ghanean, H., Ceniti, A. K., & Kennedy, S. H. (2018) · CNS Drugs · doi:10.1007/s40263-018-0490-z · Cited by 108
“Light therapy as an adjunct to pharmacotherapy has been shown to be effective, hastening and amplifying a therapeutic benefit as compared with pharmacotherapy alone [37].”
Background(2017) · PubMed · Cited by 51
Canbeyli, R. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15507 · Cited by 48
“In addition to being used as monotherapy, bright light stimulation is also utilised as an augmentation of pharmacotherapy (Al-Karawi & Jubair, 2016; Guzel Ozdemir et al., 2015; Niederhofer & Von Klitzing, 2012).”
MethodSelvı, Y., Boysan, M., Kandeğer, A., Uygur, Ö. F., Sayin, A. A., Akbaba, N., & Koc, B. O. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.018 · Cited by 46
Self-citationCunningham, J. E. A., Stamp, J. A., & Shapiro, C. M. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.04.012 · Cited by 37
Dong, S., & Jacob, T. J. C. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.01.013 · Cited by 36
Esaki, Y., Kitajima, T., Takeuchi, I., Tsuboi, S., Furukawa, O., Moriwaki, M., Fujita, K., & Iwata, N. (2017) · Chronobiology International · doi:10.1080/07420528.2017.1318893 · Cited by 34
“Regulation of the circadian rhythmmay, therefore, lead to improvement in both depression and sleep disturbances (Guzel Ozdemir et al., 2015; Lam et al., 2015).”
BackgroundCosker, E., Schwan, R., Angioï-Duprez, K., Laprévote, V., & Schwitzer, T. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.03.006 · Cited by 22
Réus, G. Z., Matias, B. I., Maciel, A. L., Abelaira, H. M., Ignácio, Z. M., de Moura, A. B., Matos, D., Danielski, L. G., Petronilho, F. C., Carvalho, A. F., et al. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.04.021 · Cited by 24
Resetting the Aging Clock: Implications for Managing Age-Related Diseases
Nobrega, A. K. D., Luz, K. V., & Lyons, L. C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-42667-5_9 · Cited by 21
Xiao, M., Feng, L., Wang, Q., Luan, X., Chen, S., & He, J. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5412 · Cited by 22
“A study found that both venlafaxine and a combination of venlafaxine and BLT significantly reversed depression in patients with severe major depressive disorder (MDD), and the latter induced significantly stronger and sooner beneficial effects.(44,45) This finding is similar to that in our study.”
ResultCostello, A., Linning-Duffy, K., Vandenbrook, C., Lonstein, J. S., & Yan, L. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2249015 · Cited by 15
Tong, H., Dong, N., Lam, C. L. M., & Lee, T. M. C. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104149 · Cited by 17
Circadian Rhythms and Mood Disorders: A Guide for the Perplexed
Lewy, A. J. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14com09716 · Cited by 14
Costello, A., Linning‐Duffy, K., Vandenbrook, C., Donohue, K. D., O’Hara, B. F., Kim, A. B., Lonstein, J. S., & Yan, L. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.012 · Cited by 16
Light Therapy for Adolescent Depression: A Scoping Review
Ballard, R., Parkhurst, J. T., Julian, K. M., Pasetes, L. N., Fawcett, A. J., Li, A., Goel, N., & Sit, D. K. Y. (2023) · Current Psychiatry Reports · doi:10.1007/s11920-023-01437-5 · Cited by 13
Morton, E. E., Michalak, E. E., LEVITT, A. J., Levitan, R. D., Cheung, A., Morehouse, R. L., Ramasubbu, R., Yatham, L. N., Tam, E. M., & Lam, R. W. M. (2020) · The Canadian Journal of Psychiatry · doi:10.1177/0706743720936470 · Cited by 14
Boysan, M. (2019) · British Journal of Guidance and Counselling · doi:10.1080/03069885.2019.1612033 · Cited by 12
Self-citationSchneider, C., Breilmann, J., Reuter, B., Becker, T. M., & Kösters, M. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13293 · Cited by 14
Cosker, E., Moulard, M., Schmitt, S., Angioi-Duprez, K., Baumann, C., Laprévote, V., Schwan, R., & Schwitzer, T. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049331 · Cited by 7
Lomnășan, A., Vintilă, B. I., Bucuță, M. D., Ștef, L., Anghel, C. E., Grama, A. M., Cornea, M., Boicean, A., Ichim, C., Paziuc, L. C., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051756 · Cited by 7
Feasibility of Adjunctive Bright Light Therapy for Depressive Symptoms on an Acute Psychiatric Floor
Trinh, A., Jain, P., Sabahath, S., Wang, D., Megna, J. L., & Leontieva, L. (2021) · Cureus · doi:10.7759/cureus.13945 · Cited by 6
“Discussion While there have been clinical trials to demonstrate the efficacy of BLT in the outpatient setting [17,18], this observational feasibility study represents a rare investigation to directly examine BLT on the acute inpatient psychiatric floor.”
MethodResultA Breakthrough Treatment for Major Depression
Kripke, D. F. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14com09644 · Cited by 5
Complementary and Alternative Therapies for Treatment-Resistant Depression: A Clinical Perspective
Yoon, R. S. Y., Ravindran, N., & Ravindran, A. V. (2018) · Springer eBooks · doi:10.1007/978-3-319-70311-4_12 · Cited by 5
Chan, J. W. Y., Li, S. X., Chau, S. W. H., Chan, N. Y., Zhang, J., & Wing, Y. K. (2022) · Clocks & Sleep · doi:10.3390/clockssleep4030029 · Cited by 3
“In terms of optimizing treatment environments and support, BLT has been used an adjunct treatment with antidepressants in hospitalized patients with depression and was shown to hasten the effect of antidepressants [34,35].”
MethodYang, C., Zhang, Z., Ma, J., & Chen, T. (2018) · PubMed Central · Cited by 2
Chronotherapy in the Treatment of Major Depression
Kang, S., & Kim, Y. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-981-95-6872-7_24 · Cited by 1
Chronobiology and Chronotherapy in Depression: Current Knowledge and Chronotherapeutic Promises
Rojas, M., Chávez-Castillo, M., Pírela, D., Ortega, Á., Salazar, J. J., Cano, C., Chacín, M., Riaño-Garzón, M., Batista, M. J., Díaz-Camargo, E. A., et al. (2020) · Current Psychiatry Research and Reviews · doi:10.2174/2666082216999201124152432 · Cited by 1
Investigating Chronotherapeutic Interventions for the Treatment of Depression
Cunningham, J. E. A. (2018) · TSpace (University of Toronto) · Cited by 2
Potentialisation de la réponse antidépressive par la lumière : étude préclinique
Delcourte, S. (2019) · theses.fr (ABES) · doi:10.70675/7468b6d3zbf12z4888z88afzc63efcc91723
Cosker, E. (2021) · theses.fr (ABES) · doi:10.70675/b38758e0zd393z4e74za68ez893e1ec6706c · Cited by 1
Lin, M., Tian, H., Xie, W., Wu, T., Huang, L., Wu, X., & Zhao, Y. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1768810
Beltrán, C. A. J., Beltran, S. C. J., Slim, L. F. F., Alcacio, F. A. S., Santiago, A. A. A., Figueroa, C. S., Flores, V. C., Poupard, I. G., Rios, L. V. G., & Lepe, L. C. M. (2026) · Cureus · doi:10.7759/cureus.117653
Metadata
- Authors
- Özdemir, P. G., Boysan, M., Smolensky, M. H., Selvi, Y., Aydin, A., & Yilmaz, E.
- Affiliations
- Van Yüzüncü Yıl Üniversitesi (TR)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2015-05-27
- Volume
- 76
- Issue
- 05
- Pages
- e645-e654
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1493162242
- Cited by
- 38
- References
- 2
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 5 · 2020: 7 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 3 · 2015: 2
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Van Yüzüncü Yıl University Academic Data Management System (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- venlafaxine, bright light therapy, phototherapy, major depressive disorder, severe depression, adjuvant therapy, antidepressant combination therapy, negative mood states, circadian rhythm, inpatient depression treatment, treatment response rate, adverse effects, sleep disorders, daytime sleepiness, anger-hostility
- MeSH terms
- Venlafaxine Hydrochloride, Adult, Combined Modality Therapy, Cyclohexanols, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Phototherapy, Severity of Illness Index, Treatment Outcome, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.